IGEA has been granted the listing of the new shares from SIX Exchange Regulation.

Hoofddorp, the Netherlands, 27September 2021. IGEA Pharma N.V. (SIX: IGPH) today announced that SIX Exchange Regulation AG (“SIX”) has granted the listing of 307’700’514 new registered shares with a nominal value of EUR 0.01 each out of authorized capital of IGEA Pharma NV, according to the International Reporting Standard of SIX Swiss Exchange.

Read More

IGEA to submit the listing prospectus to the SIX following the business combination with Blue Sky Natural Resources

Hoofddorp, the Netherlands, 06Septmeber 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the application of the listing prospectus to the SIX Swiss Exchange Ltd (“SIX”) for the admission of the New IGEA Pharma Shares to trading. The New Shares to be listed in accordance with the International Reporting Standard of SIX will be exclusively issued to current shareholders of Blue Sky Natural Resources Ltd.

Read More

IGEA Pharma to boost revenues entering the growing cannabis market

Hoofddorp, the Netherlands, 2 August 2021. IGEA Pharma N.V. (SIX: IGPH) today announced revenue expectations over the next three years of CHF264 million globally, with an expected EBITDA margin in excess of 50% and expected net results of CHF126 million of the joint venture the Group will operate in the cannabis oil (CBD) market following the combination with Blue Sky Natural Resources Ltd (“BSNR”). The expected revenue stream from the joint venture of CHF63 million along with the additional EUR 4.5 million revenues from other segments will allow IGEA Pharma to be cash positive already by the end of 2022.

Read More